June 14, 2024 · Form 4 insider transaction
HEGGIE THERESA sold 6,698 shares of BioCryst Pharmaceuticals, Inc. at $6.11 per share, a transaction worth $40.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
These shares were sold with the sole purpose of generating sufficient proceeds to cover the tax liability incurred in connection with the vesting of 16,745 Restricted Stock Units on June 13, 2024.; The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.08 to $6.15. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.